Newsfeeds Archive - Page 73 of 167

1 minute read

Rocket Pharmaceuticals To Acquire Renovacor In All-Stock Transaction Valued At ~$2.60/Share

September 20, 6:02 AM

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT), a leading late-stage, clinical biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders with high unmet

RCKT

1 minute read

General

Li-Cycle Highlights Visit By Chuck Schumer To Rochester Hub

By Bill Haddad

September 19, 4:37 PM

Li-Cycle Corp. (NYSE:LICY) ("Li-Cycle" or the "Company"), an industry leader in lithium-ion battery resource recovery and the leading lithium-ion battery recycler in North America, was pleased to

LICY

1 minute read

News

Allison eGen Power 100S Axles To Be Integrated Into Anadolu Isuzu’s Light-Duty And Midbus Platforms

By Bill Haddad

September 19, 4:31 PM

Allison Transmission, a leading designer and manufacturer of conventional, electric hybrid and fully electric vehicle propulsion solutions, is pleased to announce a strategic joint cooperation agreement (JCA) with

ALSN

1 minute read

Ford Previews Effects Of Parts Shortages On Q3 Performance; Co. Sees Q3 Adj. EBIT $1.4B-$1.7B, Reaffirms Full-Year Adj. EBIT Guidance $11.5B-$12.5B

By Bill Haddad

September 19, 4:17 PM

Expects to have about 40,000 to 45,000 vehicles in inventory at end of third quarter lacking certain parts presently in short supply Says "vehicles on wheels" awaiting those parts

1 minute read

USA NAHB Housing Market Index for Sep 46.000 vs 47.000 Est; Prior 49.000

By Bill Haddad

September 19, 10:00 AM

USA NAHB Housing Market Index for Sep 46.000 vs 47.000 consensus estimate. The prior reading was 49.000.

SPY

1 minute read

NeuroSense Announces The Peer-Reviewed Publication Of PrimeC Phase IIa ALS Study In Amyotrophic Lateral Sclerosis And Frontotemporal Degeneration

By Bill Haddad

September 19, 9:20 AM

CAMBRIDGE, Mass., Sept. 19, 2022 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today announced the

NRSN

3 minute read

Gain Therapeutics Highlights Presentation Of Preclinical Data Demonstrating Potential Disease Modifying Benefits Of Its Novel Brain Penetrant Small Molecule Candidate GT-02287 In Two Preclinical Models Of Parkinson’s Disease

By Bill Haddad

September 19, 8:02 AM

Treatment with GT-02287 Resulted in a Significant Dose-Dependent Improvement of Cellular Lysosomal Health and Fine Motor Skills Results Presented at the International Congress of Parkinson's Disease and

GANX

1 minute read

News

Earlier Tweet From Bloomberg Reporter: ‘Not that there was much doubt, but I’ve confirmed with Rockstar sources that this weekend’s massive Grand Theft Auto VI leak is indeed real’

By Bill Haddad

September 18, 9:26 PM

https://twitter.com/jasonschreier/status/1571489679534608384?s=46&t=HmmoJ9ki31tRKjxmNW0f2w

TTWO

1 minute read

Reuters Reports Saudi Arabia And Russia See $100/Barrel As A ‘ fair price that the global economy can absorb’ But ‘OPEC+ policy is not driven by defending a certain price’

By Bill Haddad

September 16, 8:10 AM

https://www.reuters.com/business/energy/opec-leaders-like-100-oil-wont-necessarily-defend-it-2022-09-16/

USO

1 minute read

Core & Main Announces Upsize And Pricing Of Secondary Offering By Selling Shareholders; Offering Now 11M shares At $23.75/Share

By Bill Haddad

September 16, 8:01 AM

Core & Main, Inc. (NYSE:CNM), a leading specialized distributor of water, wastewater, storm drainage and fire protection products, and related services, announced the upsize and pricing of the previously announced

CNM